. "Hlinomazov\u00E1, Zuzana" . . "PURPOSE: To report the clinical outcomes in patient with herpetic, bacterial and autoimmune corneal ulcers treated by tectonic, centric or eccentric penetrating keratoplasty or by tectonic sclerokeratoplasty. DESIGN: Nonrandomized clinical trial. METHODS: The study included 37 patients (37 eyes) with perforated corneal ulcers consecutively operated by two surgeons. The main patients age was 62 years (SD 7). The patients were divided into 3 groups. Group A - keratolysis in herpes eye disease, 12 patients (32%), group B - keratolysis in autoimmune diseases (rheumatoid arthritis, Wegener granulomatosis 14 patients (37%) and group C - keratolysis in bacterial corneal ulcers 11 patients (31%). The time of observation was 12 to 42 months (SD 28). BCVA and immunologic graft rejection was assessed after 3 months. All patients have used systemic immunosupression CSA and MFM during 12 to 32 months(median 16)."@cs . "Vlkov\u00E1, Eva" . "P(NR8507)" . . . "3"^^ . "RIV/00216224:14110/10:00040869" . "Tectonic penetrating keratoplasty and sclerokeratoplasty as treatment for perforated corneal ulcers of different aetiology" . . . . "14110" . . "Tectonic penetrating keratoplasty and sclerokeratoplasty as treatment for perforated corneal ulcers of different aetiology"@en . . . "Tectonic penetrating keratoplasty and sclerokeratoplasty as treatment for perforated corneal ulcers of different aetiology"@cs . "292119" . . "3"^^ . "Tectonic keratoplasty; corneal ucer"@en . . "PURPOSE: To report the clinical outcomes in patient with herpetic, bacterial and autoimmune corneal ulcers treated by tectonic, centric or eccentric penetrating keratoplasty or by tectonic sclerokeratoplasty. DESIGN: Nonrandomized clinical trial. METHODS: The study included 37 patients (37 eyes) with perforated corneal ulcers consecutively operated by two surgeons. The main patients age was 62 years (SD 7). The patients were divided into 3 groups. Group A - keratolysis in herpes eye disease, 12 patients (32%), group B - keratolysis in autoimmune diseases (rheumatoid arthritis, Wegener granulomatosis 14 patients (37%) and group C - keratolysis in bacterial corneal ulcers 11 patients (31%). The time of observation was 12 to 42 months (SD 28). BCVA and immunologic graft rejection was assessed after 3 months. All patients have used systemic immunosupression CSA and MFM during 12 to 32 months(median 16)." . "Tectonic penetrating keratoplasty and sclerokeratoplasty as treatment for perforated corneal ulcers of different aetiology"@en . "URPOSE: To report the clinical outcomes in patient with herpetic, bacterial and autoimmune corneal ulcers treated by tectonic, centric or eccentric penetrating keratoplasty or by tectonic sclerokeratoplasty. DESIGN: Nonrandomized clinical trial. METHODS: The study included 37 patients (37 eyes) with perforated corneal ulcers consecutively operated by two surgeons. The main patients age was 62 years (SD 7). The patients were divided into 3 groups. Group A - keratolysis in herpes eye disease, 12 patients (32%), group B - keratolysis in autoimmune diseases (rheumatoid arthritis, Wegener granulomatosis 14 patients (37%) and group C - keratolysis in bacterial corneal ulcers 11 patients (31%). The time of observation was 12 to 42 months (SD 28). BCVA and immunologic graft rejection was assessed after 3 months. All patients have used systemic immunosupression CSA and MFM during 12 to 32 months(median 16)."@en . "[EF4E15EAD421]" . "Tectonic penetrating keratoplasty and sclerokeratoplasty as treatment for perforated corneal ulcers of different aetiology"@cs . "RIV/00216224:14110/10:00040869!RIV11-MZ0-14110___" . "Hor\u00E1\u010Dkov\u00E1, Monika" . . . "Tectonic penetrating keratoplasty and sclerokeratoplasty as treatment for perforated corneal ulcers of different aetiology" . . .